These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


548 related items for PubMed ID: 15117913

  • 1. Eplerenone prevents salt-induced vascular remodeling and cardiac fibrosis in stroke-prone spontaneously hypertensive rats.
    Endemann DH, Touyz RM, Iglarz M, Savoia C, Schiffrin EL.
    Hypertension; 2004 Jun; 43(6):1252-7. PubMed ID: 15117913
    [Abstract] [Full Text] [Related]

  • 2. Eplerenone potentiates protective effects of amlodipine against cardiovascular injury in salt-sensitive hypertensive rats.
    Nakamura T, Fukuda M, Kataoka K, Nako H, Tokutomi Y, Dong YF, Yamamoto E, Yasuda O, Ogawa H, Kim-Mitsuyama S.
    Hypertens Res; 2011 Jul; 34(7):817-24. PubMed ID: 21471977
    [Abstract] [Full Text] [Related]

  • 3. Mineralocorticoid receptors/epithelial Na(+) channels in the choroid plexus are involved in hypertensive mechanisms in stroke-prone spontaneously hypertensive rats.
    Nakano M, Hirooka Y, Matsukawa R, Ito K, Sunagawa K.
    Hypertens Res; 2013 Mar; 36(3):277-84. PubMed ID: 23096235
    [Abstract] [Full Text] [Related]

  • 4. Endothelin antagonism on aldosterone-induced oxidative stress and vascular remodeling.
    Pu Q, Neves MF, Virdis A, Touyz RM, Schiffrin EL.
    Hypertension; 2003 Jul; 42(1):49-55. PubMed ID: 12782645
    [Abstract] [Full Text] [Related]

  • 5. Effects of combined AT1 receptor antagonist/NEP inhibitor on vascular remodeling and cardiac fibrosis in SHRSP.
    Pu Q, Brassard P, Javeshghani DM, Iglarz M, Webb RL, Amiri F, Schiffrin EL.
    J Hypertens; 2008 Feb; 26(2):322-33. PubMed ID: 18192847
    [Abstract] [Full Text] [Related]

  • 6. Eplerenone prevents salt-induced vascular stiffness in Zucker diabetic fatty rats: a preliminary report.
    Resch M, Schmid P, Amann K, Fredersdorf S, Weil J, Schach C, Birner C, Griese DP, Kreuzer P, Brunner S, Luchner A, Riegger GA, Endemann DH.
    Cardiovasc Diabetol; 2011 Oct 18; 10():94. PubMed ID: 22008236
    [Abstract] [Full Text] [Related]

  • 7. Eplerenone offsets cardiac and aortic adverse remodeling in spontaneously hypertensive rats.
    Burla AK, Neves MF, Oigman W, Mandarim-de-Lacerda CA.
    Int J Cardiol; 2007 Jan 02; 114(1):64-70. PubMed ID: 16650491
    [Abstract] [Full Text] [Related]

  • 8. Mineralocorticoid receptor activation contributes to salt-induced hypertension and renal injury in prepubertal Dahl salt-sensitive rats.
    Kawarazaki H, Ando K, Nagae A, Fujita M, Matsui H, Fujita T.
    Nephrol Dial Transplant; 2010 Sep 02; 25(9):2879-89. PubMed ID: 20466668
    [Abstract] [Full Text] [Related]

  • 9. Chronic treatment with a superoxide dismutase mimetic prevents vascular remodeling and progression of hypertension in salt-loaded stroke-prone spontaneously hypertensive rats.
    Park JB, Touyz RM, Chen X, Schiffrin EL.
    Am J Hypertens; 2002 Jan 02; 15(1 Pt 1):78-84. PubMed ID: 11824865
    [Abstract] [Full Text] [Related]

  • 10. Effects of enalapril, tempol, and eplerenone on salt-induced hypertension in dahl salt-sensitive rats.
    Bayorh MA, Mann G, Walton M, Eatman D.
    Clin Exp Hypertens; 2006 Feb 02; 28(2):121-32. PubMed ID: 16546838
    [Abstract] [Full Text] [Related]

  • 11. Mineralocorticoid receptor blockade and calcium channel blockade have different renoprotective effects on glomerular and interstitial injury in rats.
    Du J, Fan YY, Hitomi H, Kiyomoto H, Kimura S, Kong CZ, Noma T, Kohno M, Nishiyama A, Nakano D.
    Am J Physiol Renal Physiol; 2009 Sep 02; 297(3):F802-8. PubMed ID: 19535572
    [Abstract] [Full Text] [Related]

  • 12. Vascular dysfunction and fibrosis in stroke-prone spontaneously hypertensive rats: The aldosterone-mineralocorticoid receptor-Nox1 axis.
    Harvey AP, Montezano AC, Hood KY, Lopes RA, Rios F, Ceravolo G, Graham D, Touyz RM.
    Life Sci; 2017 Jun 15; 179():110-119. PubMed ID: 28478264
    [Abstract] [Full Text] [Related]

  • 13. Spironolactone improves angiotensin-induced vascular changes and oxidative stress.
    Virdis A, Neves MF, Amiri F, Viel E, Touyz RM, Schiffrin EL.
    Hypertension; 2002 Oct 15; 40(4):504-10. PubMed ID: 12364354
    [Abstract] [Full Text] [Related]

  • 14. Effects of aldosterone and angiotensin II receptor blockade on cardiac angiotensinogen and angiotensin-converting enzyme 2 expression in Dahl salt-sensitive hypertensive rats.
    Takeda Y, Zhu A, Yoneda T, Usukura M, Takata H, Yamagishi M.
    Am J Hypertens; 2007 Oct 15; 20(10):1119-24. PubMed ID: 17903697
    [Abstract] [Full Text] [Related]

  • 15. CS-3150, a novel non-steroidal mineralocorticoid receptor antagonist, prevents hypertension and cardiorenal injury in Dahl salt-sensitive hypertensive rats.
    Arai K, Tsuruoka H, Homma T.
    Eur J Pharmacol; 2015 Dec 15; 769():266-73. PubMed ID: 26607463
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 28.